PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Clinical Immunology, Auckland Hospital, Auckland; Department of Virology and Immunology, Auckland Hospital, Auckland; Department of Molecular Medicine and Pathology, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland.\', \'School of Biological Sciences, University of Auckland, Auckland.\', \'Auckland Cancer Society Research Centre, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland.\', \'School of Biological Sciences, Victoria University of Wellington, Kelburn Parade, Wellington.\', \'Department of Virology and Immunology, Auckland Hospital, Auckland.\', \'Department of Surgery, Auckland Hospital, Auckland.\', \'Department of Virology and Immunology, Auckland Hospital, Auckland; Department of Respiratory Medicine, Wellington Hospital, Wellington.\', \'Ecosure-Avisure Group, Burleigh Heads, Queensland, Australia.\', \'Callaghan Innovations, Protein Science and Engineering, Christchurch.\', \'Population Health Directorate, Counties Manukau District Health Board, Auckland.\', \'School of Pharmacy, University of Otago, Dunedin.\', \'South Pacific Sera, Timaru.\', \'Department of Microbiology and Immunology, University of Otago, Dunedin.\', \'Faculty of Medical and Health Sciences, University of Auckland, Auckland.\', \'Department of Clinical Immunology, Auckland Hospital, Auckland.\']
?:citedBy
  • -1
?:creator
?:hasPublicationType
?:journal
  • The New Zealand medical journal
is ?:pmid of
?:pmid
?:pmid
  • 32438383
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Inhaled modified angiotensin converting enzyme 2 (ACE2) as a decoy to mitigate SARS-CoV-2 infection.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all